Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmad Albshesh

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 20, 2026
Author's reply: "A critical re-evaluation of the VEDUST-EXIT study: Beyond the headline relapse rate"Ahmad Albshesh, Uri Kopylov
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 11, 2026
Author's reply: ``The ``Duration-driven'' Exit strategy: Is time the ultimate predictor of sustained remission after biologic cessation?''Ahmad Albshesh, Uri Kopylov
Expert Opinion on Biological Therapy|August 13, 2019
CT-P13: a review on a biosimilar to infliximab in the treatment of inflammatory bowel diseaseAhmad Albshesh, Shomron Ben-Horin
Alimentary Pharmacology & Therapeutics|May 20, 2020
Editorial: which biologic is next for ulcerative colitis patients who fail a subcutaneous anti-TNF?Ahmad Albshesh, Shomron Ben-Horin
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 25, 2019
Gastric SchwannomaAhmad Albshesh, Monica-Inda Kaufmann, Idan Levy
Gastroenterology|March 8, 2022
Hardly Ants-ipated Capsule Endoscopy FindingMoran Livne-Margolin, Shomron Ben-Horin, Ahmad Albshesh
Inflammatory Bowel Diseases|August 30, 2020
Terminal Ileum Thickness During Maintenance Therapy Is a Predictive Marker of the Outcome of Infliximab Therapy in Crohn DiseaseAhmad Albshesh, Bella Ungar, Shomron Ben-Horin, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|January 13, 2023
Risk of colorectal advanced neoplasia in patients with acute diverticulitis with and without previous colonoscopyAhmad Albshesh, Offir Ukashi, Adi Lahat, et al.
Endoscopy International Open|March 20, 2025
Enhancing diagnostics: ChatGPT-4 performance in ulcerative colitis endoscopic assessmentAsaf Levartovsky, Ahmad Albshesh, Ana Grinman, et al.
Therapeutic Advances in Gastroenterology|June 11, 2025
Intestinal ultrasound measurement of bowel wall thickness can be used as a sole marker for defining anti-TNF maintenance therapy failure in Crohn's diseaseAhmad Albshesh, Shadi Haj, Ido Veisman, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 20, 2026
Author's reply: "A critical re-evaluation of the VEDUST-EXIT study: Beyond the headline relapse rate"Ahmad Albshesh, Uri Kopylov
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 11, 2026
Author's reply: ``The ``Duration-driven'' Exit strategy: Is time the ultimate predictor of sustained remission after biologic cessation?''Ahmad Albshesh, Uri Kopylov
Expert Opinion on Biological Therapy|August 13, 2019
CT-P13: a review on a biosimilar to infliximab in the treatment of inflammatory bowel diseaseAhmad Albshesh, Shomron Ben-Horin
Alimentary Pharmacology & Therapeutics|May 20, 2020
Editorial: which biologic is next for ulcerative colitis patients who fail a subcutaneous anti-TNF?Ahmad Albshesh, Shomron Ben-Horin
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 25, 2019
Gastric SchwannomaAhmad Albshesh, Monica-Inda Kaufmann, Idan Levy
Gastroenterology|March 8, 2022
Hardly Ants-ipated Capsule Endoscopy FindingMoran Livne-Margolin, Shomron Ben-Horin, Ahmad Albshesh
Inflammatory Bowel Diseases|August 30, 2020
Terminal Ileum Thickness During Maintenance Therapy Is a Predictive Marker of the Outcome of Infliximab Therapy in Crohn DiseaseAhmad Albshesh, Bella Ungar, Shomron Ben-Horin, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|January 13, 2023
Risk of colorectal advanced neoplasia in patients with acute diverticulitis with and without previous colonoscopyAhmad Albshesh, Offir Ukashi, Adi Lahat, et al.
Endoscopy International Open|March 20, 2025
Enhancing diagnostics: ChatGPT-4 performance in ulcerative colitis endoscopic assessmentAsaf Levartovsky, Ahmad Albshesh, Ana Grinman, et al.
Therapeutic Advances in Gastroenterology|June 11, 2025
Intestinal ultrasound measurement of bowel wall thickness can be used as a sole marker for defining anti-TNF maintenance therapy failure in Crohn's diseaseAhmad Albshesh, Shadi Haj, Ido Veisman, et al.
Pageof 3